VISEN PHARMA-B repurchases 7,700 shares at HK$19.43 average; free float trimmed by 0.007%

Bulletin Express06-16

VISEN Pharmaceuticals (VISEN PHARMA-B) reported a share buyback executed on 16 June 2026, acquiring 7,700 ordinary shares on the Hong Kong Stock Exchange. The shares were repurchased at a high of HK$19.71 and a low of HK$19.31, giving a volume-weighted average price of HK$19.43 and a total consideration of HK$0.15 million.

Following the transaction, the number of issued shares outstanding (excluding treasury shares) fell by 0.007% to 113.78 million, while treasury shares increased to 0.15 million. Total issued share capital, including treasury shares, remained unchanged at 113.93 million.

The repurchase forms part of the mandate approved on 27 June 2025, which authorises the company to buy back up to 11.39 million shares. Cumulative repurchases under this mandate now stand at 148,400 shares, equivalent to 0.13% of the share count on the mandate date. Under listing rules, VISEN Pharma is restricted from issuing new shares or selling treasury shares until 16 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment